# DESCRIPTION

## FIELD OF INVENTION

- relate to polypeptides and nucleic acid molecules of adeno-associated virus

## BACKGROUND OF THE DISCLOSURE

- introduce gene therapy and adeno-associated virus
- limitations of current recombinant AAV virions

## SUMMARY OF THE DISCLOSURE

- identify adeno-associated virus-derived endogenous viral element
- describe nucleic acid molecules and vectors
- describe recombinant AAV virions
- describe capsid polypeptides
- describe chimeric capsid polypeptides
- describe nucleic acid molecules encoding capsid polypeptides
- describe vectors and host cells
- describe methods for introducing heterologous sequences and producing chimeric capsid genes

## DETAILED DESCRIPTION

- define technical terms
- establish reference framework
- define singular and plural forms
- define "about" and its usage
- define "comprise" and its variations
- define "vector" and its types
- define AAV-related terms (e.g., AAV vector, ITR, recombinant AAV)
- define functional capsid polypeptide and corresponding nucleotides/amino acids
- define additional terms (e.g., heterologous sequence, operably-linked, host cell, isolated, subject)
- identify mAAV-EVE1
- describe mAAV-EVE1 structure
- introduce capsid polypeptides
- describe VP1 protein
- describe VP2 protein
- describe VP3 protein
- describe fragments of capsid polypeptides
- describe functional fragments
- introduce chimeric capsid polypeptides
- describe nucleic acid molecules encoding capsid polypeptides
- introduce AAP protein
- describe AAP polypeptides
- describe fragments of AAP polypeptides
- introduce Rep protein
- describe Rep polypeptides
- describe nucleic acid molecules encoding Rep polypeptides

### Vectors

- provide vectors comprising nucleic acid molecule
- describe episomal and integrating vectors
- list exemplary vectors, including plasmids, cosmids, and viral vectors
- specify AAV vectors
- describe vectors encoding mAAV-EVE1 capsid polypeptide
- describe vectors encoding AAP protein and/or Rep protein
- describe vectors providing mAAV-EVE1 capsid polypeptides in trans
- describe vectors providing mAAV-EVE1 capsid polypeptides in cis
- describe vectors comprising heterologous sequence
- describe vectors with promoters, enhancers, and other regulatory elements
- describe vectors with posttranscriptional regulatory elements
- describe vectors with signal peptide sequences

### Recombinant AAV

- provide rAAV virions comprising mAAV-EVE1 capsid polypeptide
- describe production of rAAV using vectors and helper functions
- describe packaging cell lines and helper viruses
- describe purification of rAAV

### Host Cells

- provide host cells comprising nucleic acid molecule, vector, or rAAV virion

### Compositions and Methods

- provide pharmaceutical compositions comprising rAAV and carrier
- describe methods for introducing heterologous sequence into host cell
- describe administration of rAAV to subjects for therapeutic purposes

### Capsid Diversification

- introduce capsid diversification techniques
- describe DNA family shuffling method
- outline production of chimeric capsid genes and rAAV
- contemplate various methods and libraries produced

### Other Uses

- describe use of mAAV-EVE sequences for detecting AAV sequences
- outline PCR method for detecting AAV sequences
- describe use of mAAV-EVE sequences for assigning marsupial species
- provide disclaimer regarding prior publications

## EXAMPLES

### Example 1. Identification and Characterization of mAAV-EVE1 Genome and Proteins

- introduce sample acquisition
- describe cloning and sequencing of mAAV-EVE1 loci
- outline genomic DNA extraction and amplification
- detail PCR amplification and cloning of mAAV-EVE1 locus
- reconstruct ancestral mAAV-EVE1 sequence
- infer ancestral mAAV-EVE1 nucleotide sequences
- identify reading frames encoding rep and cap genes
- manually edit raw mAAV-EVE1 ancestral nucleotide sequence
- build 3D structure model for mAAV-EVE1
- generate VP3 monomer model
- assemble mAAV-EVE1 capsid
- describe genetic structure of mAAV-EVE1 sequences
- analyze GC-content and nucleotide substitutions
- analyze mAAV-EVE genome and proteins
- identify transcription factor binding sites
- compare mAAV-EVE NS1 promoter to AAV2 P5 promoter
- characterize Rep protein
- identify conserved protein domains in Rep protein
- model nuclease domain of Rep protein
- characterize Capsid protein
- identify phospholipase A2 domain in VP1
- model VP3 3D structure
- analyze surface topology of mAAV-EVE1 capsid

### Example 2. Modification of mAAV-EVE Capsid

- modify mAAV-EVE1 capsid protein

### Example 3. Production of rAAV

- clone mAAV-EVE1 cap gene
- co-transfect HEK293T cells
- harvest and purify rAAV
- further purify rAAV using CsCl gradient

### Example 4. Assessment of rAAV

- assess rAAV functionality

